EBS (US) share price forecast & AI signal — Emergent BioSolutions Inc

Week of 2026-10-30 · Healthcare

This week's AI signal
SELL
Confidence: Moderate (exact % inside)
1-week: SELL · 3-month: SELL · 1-month: BUY
Last close · 2026-11-06
$6.06
1 wk -11.0% · 1 mo -11.0%
Unlock the full EBS forecast

Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.

Get 5 free tokens — no card Already a member? Open the full analysis

What the model sees in EBS

Emergent BioSolutions Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a SELL with moderate confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.

About Emergent BioSolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease...

Recent closes

DateClose
2026-11-06$6.06
2026-11-05$5.85
2026-11-04$5.90
2026-11-03$6.25
2026-11-02$6.44
2026-10-30$6.81
2026-10-29$7.22

EBS FAQ

Is Emergent BioSolutions Inc (EBS) a buy or sell this week?

The ACE Stock Bots machine-learning model rates EBS a SELL for the week of 2026-10-30 with moderate confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).

What is the AI share price forecast for EBS?

Every week the model scores EBS across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.

Is this financial advice?

No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.

Other Healthcare stocks on the US

LLYJNJABBVUNHMRKAZNNVSAMGN

This week's top US picks · All US stocks

Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.